Composite grading algorithm for the National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Mapping child and adolescent self‐reported symptom data to clinician‐reported adverse event grading to improve pediatric oncology care and research

(2019) Molly McFatrich et al.   CANCER

Cabozantinib Versus Mitoxantrone-prednisone in Symptomatic Metastatic Castration-resistant Prostate Cancer: A Randomized Phase 3 Trial with a Primary Pain Endpoint

(2018) Ethan M. Basch et al.   EUROPEAN UROLOGY

Sorafenib for Advanced and Refractory Desmoid Tumors

(2018) Mrinal M. Gounder et al.   NEW ENGLAND JOURNAL OF MEDICINE

Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical Trial

(2017) Ethan Basch et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Focusing on Core Patient-Reported Outcomes in Cancer Clinical Trials—Response

(2016) Paul G. Kluetz et al.   CLINICAL CANCER RESEARCH

Methods for Implementing and Reporting Patient-reported Outcome (PRO) Measures of Symptomatic Adverse Events in Cancer Clinical Trials

(2016) Ethan Basch et al.   CLINICAL THERAPEUTICS

Patient-reported outcome measurement in drug discovery: a tool to improve accuracy and completeness of efficacy and safety data

(2016) Ethan Basch et al.   Expert Opinion on Drug Discovery

Mode equivalence and acceptability of tablet computer-, interactive voice response system-, and paper-based administration of the U.S. National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

(2016) Antonia V. Bennett et al.   Health and Quality of Life Outcomes

Validity and Reliability of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

(2015) Amylou C. Dueck et al.   JAMA Oncology

Recommended Patient-Reported Core Set of Symptoms to Measure in Adult Cancer Treatment Trials

(2014) B. B. Reeve et al.   JNCI-Journal of the National Cancer Institute

Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

(2014) E. Basch et al.   JNCI-Journal of the National Cancer Institute

Cognitive interviewing of the US National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

(2013) Jennifer L. Hay et al.   QUALITY OF LIFE RESEARCH

Comparing higher order models for the EORTC QLQ-C30

(2011) Chad M. Gundy et al.   QUALITY OF LIFE RESEARCH

Adverse Symptom Event Reporting by Patients vs Clinicians: Relationships With Clinical Outcomes

(2009) Ethan Basch et al.   JNCI-Journal of the National Cancer Institute